Ultrasound-guided nonviral gene therapy.

Harnessing microbubbles for the targeted delivery of genetic medicines to a wide range of human organs.

SonoThera is developing an ultrasound-guided nonviral gene therapy platform and therapies to provide patients with the next generation of genetic medicines.

Meet gene therapy for the 21st century


  • Non-invasive targeted delivery to most organs.


  • Our technology uses ultrasound microbubbles and hardware with an established safety track record.


  • A diversity of nucleic acid payloads of large size may be delivered.

SonoThera’s technology platform aims to overcome the most significant barriers in gene therapy such as safety, efficacy, biodistribution, and high costs of goods.